Skip to main content

Advertisement

Log in

Optimizing Expression of Streptococcus pneumoniae Surface Protein a, PspA: Serocross-Reactivity within Families of Antisera Induced Against Clades 1 and 3

  • Published:
Molecular Biotechnology Aims and scope Submit manuscript

Abstract

Streptococcus pneumoniae is the agent responsible for infections such as pneumonia, otitis media, and meningitis. Among virulence factors, the Pneumococcal surface protein A (PspA) has been shown to be immunogenic and protective in mice, and is thus a good vaccine candidate. PspA has been classified into 6 clades and 3 families. Initially, pspA fragments, clades 1 and 3, were cloned into the pAE-6His expression vector. Proteins were expressed in Escherichia coli BL21(DE3) and purified by affinity and anion exchange chromatographies, with a yield of 11 mg/l of culture. Due to plasmid instability in E. coli, another construct using pspA1 was obtained based on pET-37b(+), which was shown to be stable in E. coli and increased the yield ∼3-fold. Our results show good conditions for scale-up. Sera from immunized mice recognized PspA in total extracts of S. pneumoniae strains: anti-rPspA1p sera recognized native PspA clades 1 (+++), 2 (++) and 4 (+) and anti-rPspA3p sera recognized PspA clades 1 (+), 2 (+), 3 (+++) and 4 (+). The cross-reactivity pattern obtained confirms the notion that proteins from both families should be included for development of a broad-coverage vaccine; lower-cross reactivity between rPspAs of family 2 indicates that it may be necessary to include 2 proteins from this family.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Prescott, L. M., Harley, J. P., & Klein, D. A. (1996). Microbiology. USA: VMC BROWN Publishers.

    Google Scholar 

  2. Briles, D. E., Tart, R. C., Swiatlo, E., Dillard, J. P., Smith, P., Benton, K. A., Ralph, B. A., Brooks-Walter, A., Crain, M. J., Hollingshead, S. K., & McDaniel, L. S. (1998). Pneumococcal diversity: Considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA). Clinical Microbiology Reviews, 11, 645–657.

    PubMed  CAS  Google Scholar 

  3. Black, S., Shinefield, U., Ray, P., Edwi, L., & Fireman, B. (1998). Efficacy of heptavalente conjugate pneumococcal vaccine (Wyeth Lederle) in 37,000 infants and children: Results of northern California Keiser Permanent efficacy trial. ICAAC Abstracts, LB-9.

  4. Velasco, A. E., Verheul, A. F. M., Verhoel, J., & Snippe, H. (1995) Streptococcus pneumoniae: Virulence factors, Pathogenesis and Vaccines. Microbiological Reviews 59, 591–603.

    Google Scholar 

  5. McDaniel, L. S., Scott, G., Kearney J. F., & Brilles, D. E. (1984). Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae. Journal of Experimental Medicine, 160, 386–397.

    Article  PubMed  CAS  Google Scholar 

  6. Crain, M. J., Waltman, W. D., Turner, J. S., Yother, J., Talkington, D. F., McDaniel, L. S., Gray, B. M., & Brilles, D. E. (1990). Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular seritypes of Streptococcus pneumoniae. Infection and Immunity, 58, 3293–3299.

    PubMed  CAS  Google Scholar 

  7. Waltman, W. D., MaDaniel, L. S., Gray, B. M., & Brilles, D. E. (1990). Variation in the molecular weight of PspA (pneumococcal surface protein A) among Streptococcus pneumoniae. Microbial Pathogenesis, 8, 61–60.

    Article  PubMed  CAS  Google Scholar 

  8. ANH-Hue, T. T., Fulgham, R. L., McCrory, M. A., Brilles, D. E., & Szalai, A. J. (1999). Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae. Infection and Immunity, 67, 4720–4724.

    Google Scholar 

  9. Yother, J., & Brilles, D. E. (1992). Structural properties and evolutionary relationships of PspA, a surface protein of Streptococcus pneumoniae, as revealed by sequence analises. Journal of Bacteriology, 174, 601–609.

    PubMed  CAS  Google Scholar 

  10. Hollingdhead, S. K., Becker, R., & Briles, D. E. (2000). Diversity of PspA: Mosaic genes and evidence for past recombination in Streptococcus pneumoniae. Infection and Immunity ,68, 5889–5900.

    Article  Google Scholar 

  11. Briles, D. E., Hollingshead, S. K., King, J., Swift, A., Braun, P. A., Park, M. K., Ferguson, L. M., Nahm, M. H., & Nabors, G. S. (2000). Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA. Journal of Infectious Diseases, 182(6), 1694–1701.

    Article  PubMed  CAS  Google Scholar 

  12. Kolberg, J., Aase, A., Rodal, G., Littlejohn, J. E., & Jedrzejas, M. J. (2003). Epitope mapping of pneumococcal surface protein A of strain Rx1 using monoclonal antibodies and molecular structure modeling. FEMS, 39, 265–273.

    CAS  Google Scholar 

  13. Nabors, G. S., Braun, P. A., Herrmann, D. J., Heise, M. L., Pyle, D. J., Gravenstein, S., Schilling, M., Ferguson, L. M., Hollingshead, S. K., Briles, D. E., & Becker, R. S. (2000). Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules. Vaccine, 18, 1743–1754.

    Article  PubMed  CAS  Google Scholar 

  14. Miyaji, E. N., Ferreira, D. M., Lopes, A. P., Brandileone, M. C., Dias, W. O., & Leite, L. C. (2002). Analysis of serum cross-reactivity and cross-protection elicited by immunization with DNA vaccines against Streptococcus pneumoniae expressing PspA fragments from different clades. Infection and Immunity, 70, 5086–5090.

    Article  PubMed  CAS  Google Scholar 

  15. Pimenta, F. C., Ribeiro-Dias, F., Brandileone, M. C., Miyaji, E. N., Leite, L. C., & Sgambatti de Andrade, A. L. (2006). Genetic diversity of PspA types among nasopharyngeal isolates collected during an ongoing surveillance study of children in Brazil. Journal Clinical Microbiology, 44, 2838–2843.

    Google Scholar 

  16. Ramos, C. R., Abreu, P. A., Nascimento, A. L., & Ho, P. L. (2004). A high-copy T7 Escherichia coli expression vector for the production of recombinant proteins with a minimal N-terminal His-tagged fusion peptide. Brazilian Journal of Médical and Biological Research, 37, 1103–1109.

    PubMed  CAS  Google Scholar 

  17. Lamani, E., McPherson, D. T., Hollingshead, S. K., & Jedrzejas, M. J. (2000). Production, characterization, and crystallization of truncated forms of pneumococcal surface protein A from Escherichia coli. Protein Expression and Purification, 20(3), 379–388.

    Article  PubMed  CAS  Google Scholar 

  18. Jedrzejas, M. J., Hollingshead, S. K., Lebowitz, J., Chantalat, L., Briles D. E., & Lamani, E. (2000). Production and characterization of the functional fragment of pneumococcal surface protein A. Archives of Biochemistry and Biophysics, 373(1), 116–125.

    Article  PubMed  CAS  Google Scholar 

  19. Cebolla, A., Royo, J. L., De Lorenzo, V., & Santero, E. (2002). Improvement of recombinant protein yield by a combination of transcriptional amplification and stabilization of gene expression. Applied and Environmental Microbiology, 68, 5034–5041.

    Article  PubMed  CAS  Google Scholar 

  20. Williams, S. G., Cranenburgh, R. M., Weiss, A. M., Wrighton, C. J., Sherratt, D. J., & Hanak, J. A. (1998). Repressor titration: A novel system for selection and stable maintenance of recombinant plasmids. Nucleic Acids Research, 26, 2120–2124.

    Article  PubMed  CAS  Google Scholar 

  21. Fiedler, M., & Skerra, A. (2001). proBA complementation of an auxotrophic E. coli strain improves plasmid stability and expression yield during fermenter production of a recombinant antibody fragment. Gene, 274, 111–118.

    Article  PubMed  CAS  Google Scholar 

  22. Kolodny, N., Kitov, S., Vassell, M. A., Miller, V. L., Ware, L. A., Fegeding, K., De La Vega, P., Sacci, J. B. Jr., & Lanar, D. E. (2001). Two-step chromatographic purification of recombinant Plasmodium falciparum circumsporozoite protein from Escherichia coli. Journal of Chromatography B-Biomedical Science Applications, 762, 77–86.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

We thank Dr. Mickie Takagi and Dr. Ivan P. Nascimento for assistance during bacterial cultivation and protein analysis. We also thank Ines A. Maurelli, Lourivaldo I. de Souza, Marisa G. Trevelin, Solange R. Silva, Sebastiana V. Oliveira and Sueli G. Pedroza for technical assistance and Fatima A. M. Oliveira for secretarial assistance. This work received financial support from FAPESP, CNPq, and Fundação Butantan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alexandre P. Y. Lopes.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Silva, M., Cabrera-Crespo, J., Sbrogio-Almeida, M.E. et al. Optimizing Expression of Streptococcus pneumoniae Surface Protein a, PspA: Serocross-Reactivity within Families of Antisera Induced Against Clades 1 and 3. Mol Biotechnol 37, 146–154 (2007). https://doi.org/10.1007/s12033-007-0043-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12033-007-0043-z

Keywords

Navigation